NDTDI

NDTDI is a tricyclic tryptamine derivative which is thought to act as a serotonin receptor agonist, though its pharmacology has not been studied in detail. It is a structurally simplified analogue of LSD and is reported to retain similar effects, though with many times lower potency. It has been sold as a designer drug since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.[1]

NDTDI
Legal status
Legal status
  • Illegal in Latvia
Identifiers
Chemical and physical data
FormulaC19H27N3O
Molar mass313.445 g·mol−1
3D model (JSmol)

Legality

NDTDI was made illegal in Latvia in March 2017.[2]

See also

References
  1. Analytical Report: NDTDI. Nacionalni Forenzični Laboratorij, Slovenia, June 2017
  2. Par aizlieguma noteikšanu vielai NDTDI un tās saturošiem izstrādājumiem.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.